Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study-Reference-Cited by-同舟云学术

Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study

Published:2019-06 Issue:12 Volume:123 Page:1921-1926
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Park Jiesuck,Choi Eue-Keun^ORCID,Han Kyung-Do,Choi You-Jung,Lee So-Ryoung,Cha Myung-Jin,Kang Jeehoon,Park Kyung Woo,Oh Seil^ORCID,Lip Gregory Y.H.

Funder

Seoul National University Hospital Research Fund

National Research Foundation of Korea

Ministry of Education, Science and Technology

Technology Innovation Program or Industrial Strategic Technology Development Program

Ministry of Trade, Industry and Energy

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Antithrombotic therapy for atrial fibrillation: chest guideline and expert panel report;Lip;Chest,2018

2. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making;Lip;Thromb Haemost,2017

3. Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention, a North American perspective-2018 update;Angiolillo;Circulation,2018

4. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

5. Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: a nationwide population-based study;Lee;PLoS One,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Optimal Duration and De-escalation Strategy of Antiplatelet Agents and Anticoagulation Agents in Korean Patients Undergoing Percutaneous Coronary Intervention;CardioMetabolic Syndrome Journal;2023

2. Comparative Effectiveness and Safety of Different Combinations of Antithrombotic Regimens in Atrial Fibrillation Patients With Stent Insertions;Clinical Pharmacology & Therapeutics;2022-07-02

3. Treatment Pattern of Antithrombotic Therapy over Time after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation in Real-World Practice in Korea;Healthcare;2021-09-09

4. Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents;Journal of Clinical Medicine;2021-07-29

5. Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study;Journal of Clinical Medicine;2021-04-04